27941491|t|Low intensity sprint training with blood flow restriction improves 100 m dash
27941491|a|We investigated the effects of practical blood flow restriction (pBFR) of leg muscles during sprint training on the 100 m dash time in well-trained sport students. Participants performed 6x100 m sprints at 60-70% of their maximal 100 m sprinting speed twice a week for 6 weeks, either with (IG; n=12) or without pBFR (CG; n=12). The 100 m dash time significantly decreased more in the IG (-0.38±0.24 s) than in the CG (-0.16±0.17 s). The muscle thickness of the rectus femoris increased only in the IG, while no group by time interactions were found for the muscle thickness of the biceps femoris and the biceps brachii. The maximal isometric force, measured using a leg press, did not change in either group. However, the rate of force development improved in the IG. Growth hormone, testosterone, insulin-like growth factor 1, and cortisol concentrations did not significantly differ between both groups at any measurement time point (pre, 1 min, 20 min, 120 min, and 24 h after the six all-out sprints of the first training session). The muscle damage marker h-FABP increased significantly more in the CG than in the IG. The pBFR improved the 100 m dash time significantly more than low - intensity sprint interval training alone. Other noted benefits of training with pBFR were a decreased level of muscle damage, a greater increase of the rectus femoris muscle thickness, and a higher rate of force development. However, the tested hormones were unable to explain the additional beneficial effects.
27941491	0	3	Low	T080	C0205251
27941491	4	13	intensity	T080	C0522510
27941491	14	29	sprint training	T061	C0454374
27941491	35	57	blood flow restriction	T065	C0220931
27941491	81	93	investigated	T169	C1292732
27941491	98	108	effects of	T080	C1704420
27941491	109	141	practical blood flow restriction	T065	C0220931
27941491	143	147	pBFR	T065	C0220931
27941491	152	163	leg muscles	T023	C0224456
27941491	171	186	sprint training	T061	C0454374
27941491	205	209	time	T079	C0040223
27941491	213	240	well-trained sport students	T098	C0038492
27941491	242	254	Participants	T098	C0679646
27941491	273	280	sprints	T056	C0035953
27941491	314	329	sprinting speed	T081	C0678536
27941491	330	342	twice a week	T079	C0556985
27941491	349	354	weeks	T079	C0439230
27941491	369	371	IG	T098	C2986530
27941491	390	394	pBFR	T065	C0220931
27941491	396	398	CG	T096	C0009932
27941491	422	426	time	T079	C0040223
27941491	441	450	decreased	T081	C0205216
27941491	463	465	IG	T098	C2986530
27941491	493	495	CG	T096	C0009932
27941491	516	522	muscle	T024	C0026845
27941491	523	532	thickness	T080	C1280412
27941491	540	554	rectus femoris	T023	C0584894
27941491	555	564	increased	T081	C0205217
27941491	577	579	IG	T098	C2986530
27941491	590	595	group	T078	C0441833
27941491	599	603	time	T079	C0040223
27941491	604	616	interactions	T169	C1704675
27941491	636	642	muscle	T024	C0026845
27941491	643	652	thickness	T080	C1280412
27941491	660	674	biceps femoris	T023	C0224449
27941491	683	697	biceps brachii	T023	C0559499
27941491	703	726	maximal isometric force	T081	C0392762
27941491	745	754	leg press	T056	C4054656
27941491	760	770	not change	T033	C0442739
27941491	781	786	group	T078	C0441833
27941491	801	826	rate of force development	T081	C0392762
27941491	843	845	IG	T098	C2986530
27941491	847	861	Growth hormone	T116,T121,T125	C0037663
27941491	863	875	testosterone	T109,T121,T125	C0039601
27941491	877	905	insulin-like growth factor 1	T116,T123	C0021665
27941491	911	919	cortisol	T109,T121,T125	C0020268
27941491	920	934	concentrations	T081	C0392762
27941491	939	963	not significantly differ	T033	C0243095
27941491	977	983	groups	T078	C0441833
27941491	991	1002	measurement	T169	C0242485
27941491	1003	1013	time point	T079	C2348792
27941491	1075	1082	sprints	T056	C0035953
27941491	1096	1104	training	T065	C0220931
27941491	1105	1112	session	T051	C1883016
27941491	1119	1132	muscle damage	T020	C0410158
27941491	1133	1139	marker	T201	C0005516
27941491	1140	1146	h-FABP	T116,T123	C1312696
27941491	1147	1156	increased	T081	C0205217
27941491	1183	1185	CG	T096	C0009932
27941491	1198	1200	IG	T098	C2986530
27941491	1206	1210	pBFR	T065	C0220931
27941491	1235	1239	time	T079	C0040223
27941491	1264	1267	low	T080	C0205251
27941491	1270	1279	intensity	T080	C0522510
27941491	1280	1304	sprint interval training	T061	C0454374
27941491	1324	1332	benefits	T081	C0814225
27941491	1336	1344	training	T065	C0220931
27941491	1350	1354	pBFR	T065	C0220931
27941491	1362	1371	decreased	T081	C0205216
27941491	1372	1377	level	T080	C0441889
27941491	1381	1394	muscle damage	T020	C0410158
27941491	1406	1414	increase	T169	C0442805
27941491	1422	1443	rectus femoris muscle	T023	C0584894
27941491	1444	1453	thickness	T080	C1280412
27941491	1461	1467	higher	T080	C0205250
27941491	1468	1493	rate of force development	T081	C0392762
27941491	1508	1514	tested	T169	C0039593
27941491	1515	1523	hormones	T125	C0019932
27941491	1562	1580	beneficial effects	T080	C1280500